[1] |
HOOGENDIJK E O, AFILALO J, ENSRUD K E, et al. Frailty:implications for clinical practice and public health[J]. Lancet, 2019, 394(10206):1365-1375. DOI: 10.1016/S0140-6736(19)31786-6.
|
[2] |
KAWADA T. Frailty and all-cause mortality in older adults:a risk assessment[J]. J Am Med Dir Assoc, 2021, 22(8):1774. DOI: 10.1016/j.jamda.2021.03.006.
|
[3] |
SÁNCHEZ-GARCÍA S, GARCÍA-PEÑA C, SALVÀ A, et al. Frailty in community-dwelling older adults:association with adverse outcomes[J]. Clin Interv Aging, 2017, 12:1003-1011. DOI: 10.2147/CIA.S139860.
|
[4] |
O'CAOIMH R, SEZGIN D, O'DONOVAN M R, et al. Prevalence of frailty in 62 countries across the world:a systematic review and meta-analysis of population-level studies[J]. Age Ageing, 2021, 50(1):96-104. DOI: 10.1093/ageing/afaa219.
|
[5] |
PICCA A, COELHO-JUNIOR H J, CALVANI R, et al. Biomarkers shared by frailty and sarcopenia in older adults:a systematic review and meta-analysis[J]. Ageing Res Rev, 2022, 73:101530. DOI: 10.1016/j.arr.2021.101530.
|
[6] |
AROSIO B, FERRI E, MARI D, et al. The influence of inflammation and frailty in the aging continuum[J]. Mech Ageing Dev, 2023, 215:111872. DOI: 10.1016/j.mad.2023.111872.
|
[7] |
BODOLEA C, HIRISCAU E I, BUZDUGAN E C, et al. The association between peripheral blood cells and the frailty syndrome in patients with cardiovascular diseases[J]. Endocr Metab Immune Disord Drug Targets, 2020, 20(9):1419-1433. DOI: 10.2174/1871530320666200813135905.
|
[8] |
HOU P, XUE H P, MAO X E, et al. Inflammation markers are associated with frailty in elderly patients with coronary heart disease[J]. Aging, 2018, 10(10):2636-2645. DOI: 10.18632/aging.101575.
|
[9] |
NISHIJIMA T F, DEAL A M, WILLIAMS G R, et al. Frailty and inflammatory markers in older adults with cancer[J]. Aging, 2017, 9(3):650-664. DOI: 10.18632/aging.101162.
|
[10] |
CHEONG C Y, NYUNT M S Z, GAO Q, et al. Risk factors of progression to frailty:findings from the Singapore longitudinal ageing study[J]. J Nutr Health Aging, 2020, 24(1):98-106. DOI: 10.1007/s12603-019-1277-8.
|
[11] |
ZHANG Z H, XU X, NI H Y, et al. Red cell distribution width is associated with hospital mortality in unselected critically ill patients[J]. J Thorac Dis, 2013, 5(6):730-736. DOI: 10.3978/j.issn.2072-1439.2013.11.14.
|
[12] |
|
[13] |
中国老年医学学会营养与食品安全分会,中国循证医学中心,《中国循证医学杂志》编辑委员会,等. 老年患者家庭营养管理中国专家共识(2017版)[J]. 中国循证医学杂志, 2017, 17(11):1251-1259. DOI: 10.7507/1672-2531.201707095.
|
[14] |
HANLON P, NICHOLL B I, JANI B D, et al. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality:a prospective analysis of 493 737 UK Biobank participants[J]. Lancet Public Health, 2018, 3(7):e323-332. DOI: 10.1016/S2468-2667(18)30091-4.
|
[15] |
VETRANO D L, PALMER K, MARENGONI A, et al. Frailty and multimorbidity:a systematic review and meta-analysis[J]. J Gerontol A Biol Sci Med Sci, 2019, 74(5):659-666. DOI: 10.1093/gerona/gly110.
|
[16] |
GUTIÉRREZ-VALENCIA M, IZQUIERDO M, CESARI M, et al. The relationship between frailty and polypharmacy in older people:a systematic review[J]. Br J Clin Pharmacol, 2018, 84(7):1432-1444. DOI: 10.1111/bcp.13590.
|
[17] |
YU K M, TAKAHASHI T, ITAKURA Y, et al. Polypharmacy and lack of joy are related to physical frailty among northern Japanese community-dwellers from the ORANGE cohort study[J]. Gerontology,2021,67(2):184-193.
|
[18] |
WEI K, NYUNT M S Z, GAO Q, et al. Frailty and malnutrition:related and distinct syndrome prevalence and association among community-dwelling older adults:Singapore longitudinal ageing studies[J]. J Am Med Dir Assoc, 2017, 18(12):1019-1028. DOI: 10.1016/j.jamda.2017.06.017.
|
[19] |
WEI K, NYUNT M S, GAO Q, et al. Association of frailty and malnutrition with long-term functional and mortality outcomes among community-dwelling older adults:results from the Singapore longitudinal aging study 1[J]. JAMA Netw Open, 2018, 1(3):e180650. DOI: 10.1001/jamanetworkopen.2018.0650.
|
[20] |
SUN P, ZHANG F, CHEN C, et al. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma:a retrospective study from Southern China[J]. Oncotarget, 2016, 7(27):42650-42660. DOI: 10.18632/oncotarget.9516.
|
[21] |
QU J L, ZHOU T, XUE M X, et al. Correlation analysis of hemoglobin-to-red blood cell distribution width ratio and frailty in elderly patients with coronary heart disease[J]. Front Cardiovasc Med, 2021, 8:728800. DOI: 10.3389/fcvm.2021.728800.
|
[22] |
KINOSHITA K, SATAKE S, MUROTANI K, et al. Physical frailty and hemoglobin-to-red cell distribution width ratio in Japanese older outpatients[J]. J Frailty Aging, 2022, 11(4):393-397. DOI: 10.14283/jfa.2022.49.
|
[23] |
STEINMEYER Z, DELPIERRE C, SORIANO G, et al. Hemoglobin concentration;a pathway to frailty[J]. BMC Geriatr, 2020, 20(1):202. DOI: 10.1186/s12877-020-01597-6.
|
[24] |
KIM K M, LUI L Y, BROWNER W S, et al. Association between variation in red cell size and multiple aging-related outcomes[J]. J Gerontol A Biol Sci Med Sci, 2021, 76(7):1288-1294. DOI: 10.1093/gerona/glaa217.
|
[25] |
KIM J, IM J S, CHOI C H, et al. The association between red blood cell distribution width and sarcopenia in U.S. adults[J]. Sci Rep,2018,8(1):11484.
|